{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:54:37Z","timestamp":1776448477269,"version":"3.51.2"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1038\/s41390-023-02747-3","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T12:02:36Z","timestamp":1690200156000},"page":"2040-2046","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and safety of multi-target therapy in children with lupus nephritis"],"prefix":"10.1038","volume":"94","author":[{"given":"Xiaohong","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"2747_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1191\/0961203302lu158oa","volume":"11","author":"HM Bastian","year":"2002","unstructured":"Bastian, H. M. et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 11, 152\u2013160 (2002).","journal-title":"Lupus"},{"key":"2747_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1191\/9612332lu155oa","volume":"11","author":"GS Alarc\u00f3n","year":"2002","unstructured":"Alarc\u00f3n, G. S. et al. Baseline characteristics of a multiethnic lupus cohort PROFILE. Lupus 11, 95\u2013101 (2002).","journal-title":"Lupus"},{"key":"2747_CR3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/art.37795","volume":"65","author":"CH Feldman","year":"2013","unstructured":"Feldman, C. H. et al. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. Arthritis Rheum. 65, 753\u2013763 (2013).","journal-title":"Arthritis Rheum."},{"key":"2747_CR4","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/art.38006","volume":"65","author":"CC Mok","year":"2013","unstructured":"Mok, C. C., Kwok, R. C. L. & Yip, P. S. F. Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus. Arthritis Rheum. 65, 2154\u20132160 (2013).","journal-title":"Arthritis Rheum."},{"key":"2747_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00467-010-1640-9","volume":"26","author":"S Sule","year":"2011","unstructured":"Sule, S. et al. Increased risk of death in pediatric and adult patients with ESRD secondary to lupus. Pediatr. Nephrol. 26, 93\u201398 (2011).","journal-title":"Pediatr. Nephrol."},{"key":"2747_CR6","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1093\/ndt\/gfs073","volume":"27","author":"DY Yap","year":"2012","unstructured":"Yap, D. Y. et al. Survival analysis and causes of mortality in patients with lupus nephritis. Nephrol. Dial. Transplant. 27, 3248\u20133254 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"2747_CR7","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/art.34472","volume":"64","author":"LT Hiraki","year":"2012","unstructured":"Hiraki, L. T. et al. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum. 64, 2669\u20132676 (2012).","journal-title":"Arthritis Rheum."},{"key":"2747_CR8","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group.","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 100, S1\u2013S276 (2021).","journal-title":"Kidney Int."},{"key":"2747_CR9","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1681\/ASN.2008101028","volume":"20","author":"GB Appel","year":"2009","unstructured":"Appel, G. B. et al. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J. Am. Soc. Nephrol. 20, 1103\u20131112 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2747_CR10","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1056\/NEJM200010193431604","volume":"343","author":"TM Chan","year":"2000","unstructured":"Chan, T. M. et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N. Engl J. Med. 343, 1156\u20131162 (2000).","journal-title":"N. Engl J. Med."},{"key":"2747_CR11","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa043731","volume":"353","author":"EM Ginzler","year":"2005","unstructured":"Ginzler, E. M. et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N. Engl J. Med. 353, 2219\u20132228 (2005).","journal-title":"N. Engl J. Med."},{"key":"2747_CR12","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1097\/00007890-199306000-00023","volume":"55","author":"SC Textor","year":"1993","unstructured":"Textor, S. C. et al. Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. Transplantation 55, 1332\u20131339 (1993).","journal-title":"Transplantation"},{"key":"2747_CR13","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/ki.1995.200","volume":"47","author":"SC Textor","year":"1995","unstructured":"Textor, S. C. et al. Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation. Kidney Int. 47, 1426\u20131433 (1995).","journal-title":"Kidney Int."},{"key":"2747_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1159\/000337175","volume":"35","author":"Q Zhang","year":"2012","unstructured":"Zhang, Q. et al. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy. Am. J. Nephrol. 35, 312\u2013320 (2012).","journal-title":"Am. J. Nephrol."},{"key":"2747_CR15","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1681\/ASN.2007121272","volume":"19","author":"H Bao","year":"2008","unstructured":"Bao, H. et al. Successful treatment of class V+IV lupus nephritis with multitarget therapy. J. Am. Soc. Nephrol. 19, 2001\u20132010 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2747_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.18433\/jpps30526","volume":"22","author":"T Zhou","year":"2019","unstructured":"Zhou, T. et al. Multitarget therapy: an effective and safe therapeutic regimen for lupus nephritis. J. Pharm. Pharm. Sci. 22, 365\u2013375 (2019).","journal-title":"J. Pharm. Pharm. Sci."},{"key":"2747_CR17","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3906\/sag-1804-57","volume":"48","author":"J Deng","year":"2018","unstructured":"Deng, J. et al. Multitarget therapy versus intravenous cyclophosphamide in the induction treatment of lupus nephritis: a metaanalysis of randomized controlled trials. Turk. J. Med. Sci. 48, 901\u2013910 (2018).","journal-title":"Turk. J. Med. Sci."},{"key":"2747_CR18","first-page":"100","volume":"17","author":"JP Huang","year":"2017","unstructured":"Huang, J. P. et al. Clinical studies on the effectiveness and safety of multi-target induction therapy for proliferative and membranous lupus nephritis. J. Clin. Nephrol. 17, 100\u2013104 (2017).","journal-title":"J. Clin. Nephrol."},{"key":"2747_CR19","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1681\/ASN.2017030263","volume":"28","author":"H Zhang","year":"2017","unstructured":"Zhang, H. et al. Multitarget therapy for maintenance treatment of lupus nephritis. J. Am. Soc. Nephrol. 28, 3671\u20133678 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2747_CR20","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg, M. C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40, 1725\u20131725 (1997).","journal-title":"Arthritis Rheum."},{"key":"2747_CR21","first-page":"88","volume":"56","author":"Nephrology Group, Pediatrics Branch of Chinese Medical Association.","year":"2018","unstructured":"Nephrology Group, Pediatrics Branch of Chinese Medical Association. Evidence-based Guidelines for the Diagnosis and Treatment of Lupus Nephritis (2016). Chin. J. Pediatr. 56, 88\u201394 (2018).","journal-title":"Chin. J. Pediatr."},{"key":"2747_CR22","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","volume":"65","author":"JJ Weening","year":"2004","unstructured":"Weening, J. J. et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 65, 521\u2013530 (2004).","journal-title":"Kidney Int."},{"key":"2747_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz, G. J. et al. New equations to estimate GFR in children with CKD. J. Am. Soc. Nephrol. 20, 629\u2013637 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2747_CR24","first-page":"835","volume":"56","author":"XH Zhong","year":"2018","unstructured":"Zhong, X. H. et al. A multicenter study of reference intervals for 15 laboratory parameters in Chinese children. Chin. J. Pediatr. 56, 835\u2013845 (2018).","journal-title":"Chin. J. Pediatr."},{"key":"2747_CR25","first-page":"729","volume":"55","author":"Nephrology Group, Pediatrics Branch of Chinese Medical Association.","year":"2017","unstructured":"Nephrology Group, Pediatrics Branch of Chinese Medical Association. Evidence-based guideline on diagnosis and treatment of steroid-sensitive, relapsing\/steroid-dependent nephrotic syndrome in children (2016). Chin. J. Pediatr. 55, 729\u2013734 (2017).","journal-title":"Chin. J. Pediatr."},{"key":"2747_CR26","doi-asserted-by":"publisher","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","volume":"140","author":"J Flynn","year":"2017","unstructured":"Flynn, J. et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140, e20171904 (2017).","journal-title":"Pediatrics"},{"key":"2747_CR27","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1681\/ASN.2018010090","volume":"29","author":"X Xu","year":"2018","unstructured":"Xu, X. et al. A new criterion for pediatric AKI based on the reference change value of serum creatinine. J. Am. Soc. Nephrol. 29, 2432\u20132442 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2747_CR28","doi-asserted-by":"crossref","unstructured":"Adler, A. et al. Reprint of: classification of diabetes mellitus. Diabetes Res. Clin. Pract. 199, 108972 (2021).","DOI":"10.1016\/j.diabres.2021.108972"},{"key":"2747_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jpeds.2012.06.008","volume":"162","author":"DG Noone","year":"2013","unstructured":"Noone, D. G. & Marks, S. D. Hyperuricemia is associated with hypertension, obesity, and albuminuria in children with chronic kidney disease. J. Pediatr. 162, 128\u2013132 (2013).","journal-title":"J. Pediatr."},{"key":"2747_CR30","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","volume":"71","author":"GK Bertsias","year":"2012","unstructured":"Bertsias, G. K. et al. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann. Rheum. Dis. 71, 1771\u20131782 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"2747_CR31","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1136\/annrheumdis-2020-216965","volume":"79","author":"G Moroni","year":"2020","unstructured":"Moroni, G. et al. Lack of EULAR\/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis. Ann. Rheum. Dis. 79, 1077\u20131083 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"2747_CR32","first-page":"664","volume":"32","author":"J Fang","year":"2017","unstructured":"Fang, J. et al. Efficacy and safety of multiple target therapy for lupus nephritis in children. Chin. J. Appl. Clin. Pediatr. 32, 664\u2013667 (2017).","journal-title":"Chin. J. Appl. Clin. Pediatr."},{"key":"2747_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ekir.2022.10.014","volume":"8","author":"EY Chan","year":"2023","unstructured":"Chan, E. Y. et al. Long-term outcomes of children and adolescents with biopsy-proven childhood-onset lupus nephritis. Kidney Int. Rep. 8, 141\u2013150 (2023).","journal-title":"Kidney Int. Rep."},{"key":"2747_CR34","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1093\/rheumatology\/keu265","volume":"53","author":"DY Yap","year":"2014","unstructured":"Yap, D. Y. et al. Long-term data on tacrolimus treatment in lupus nephritis. Rheumatology (Oxford) 53, 2232\u20132237 (2014).","journal-title":"Rheumatology (Oxford)"},{"key":"2747_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.7326\/M14-1030","volume":"162","author":"Z Liu","year":"2015","unstructured":"Liu, Z. et al. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial. Ann. Intern Med. 162, 18\u201326 (2015).","journal-title":"Ann. Intern Med."},{"key":"2747_CR36","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1177\/0961203312458466","volume":"21","author":"R Sundel","year":"2012","unstructured":"Sundel, R. et al. Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial. Lupus 21, 1433\u20131443 (2012).","journal-title":"Lupus"},{"key":"2747_CR37","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1136\/annrheumdis-2017-211898","volume":"76","author":"N Groot","year":"2017","unstructured":"Groot, N. et al. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. Ann. Rheum. Dis. 76, 1965\u20131973 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"2747_CR38","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1056\/NEJMoa020009","volume":"349","author":"BJ Nankivell","year":"2003","unstructured":"Nankivell, B. J. et al. The natural history of chronic allograft nephropathy. N. Engl J. Med. 349, 2326\u20132333 (2003).","journal-title":"N. Engl J. Med."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02747-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02747-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02747-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T16:04:46Z","timestamp":1700669086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02747-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["2747"],"URL":"https:\/\/doi.org\/10.1038\/s41390-023-02747-3","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,24]]},"assertion":[{"value":"24 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital, Sun Yat-sen University (No. [2019] 248), and all the children and their guardians were informed and signed the consent forms before collecting clinical data and specimens.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}